Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics

Synapse

Volumn 54, Issue 3, 2004, Pages 147-155

  Pantazopoulos, Harry ^a   Stone, David ^a   Walsh, John ^a   Benes, Francine M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CA3 CA2; Dopamine; Gene expression; In situ hybridization

Indexed keywords

DOPAMINE 1 RECEPTOR; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BIPOLAR DISORDER; CADAVER; CELLULAR DISTRIBUTION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NEUROIMAGING; NEUROMODULATION; NEUROPATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RECEPTOR DENSITY; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEURONS; POSTMORTEM CHANGES; RECEPTORS, DOPAMINE D1; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 7244258768     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20076     Document Type: Article

References (50)

1. Abi-Dargham A, Moore H. 2003. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9:404-416.
2. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M. 2002. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22:3708-3719.
3. Benes FM. 1995. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch Gen Psychiatry 52:1015-1018; discussion 1019-1024.
4. Benes FM. 1997. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res 31:257-275.
5. Benes FM. 1999. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol Psychiatry 46:589-599.
6. Benes FM. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31:251-269.
7. Benes FM, Berretta S. 2000. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann NY Acad Sci 911:293-304.
8. Benes FM, Berretta S. 2001. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27.
9. Benes FM, Todtenkopf MS. 1999. Effect of age and neuroleptics on tyrosine hydroxylase-IR in sector CA2 of schizophrenic brain. Neuroreport 10:3527-3530.
10. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. 1992. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12:924-929.
11. Benes FM, Vincent SL, Molloy R. 1993. Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA-immunoreactive neurons of rat medial prefrontal cortex. Synapse 15:285-295.
12. Benes FM, Todtenkopf MS, Taylor JB. 1995. A shift in tyrosine hydroxylase-immunoreactive varicosities (TH-IRv) from pyramidal (PN) to nonpyramidal (NP) neurons in layer II of the anterior cingulate cortex of schizophrenics. Soc Neurosci Abs 21:110-112.
13. Benes FM, Todtenkopf MS, Taylor JB. 1997. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 25:80-92.
14. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. 1998. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives [see Comments]. Biol Psychiatry 44:88-97.
15. Benes FM, Todtenkopf MS, Kostoulakos P. 2001. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11:482-491.
16. Berretta S, Munno DW, Benes FM. 2001. Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia. J Comp Neurol 431:129-138.
17. Boska P, Zhang Y, Bestawros A. 2002. Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences. Exp Neurol 175:388-397.
18. Castner SA, Williams GV, Goldman-Rakic PS. 2000. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287:2020-2022.
19. Goldman-Rakic PS, Muly 3rd EC, Williams GV. 2000. D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31:295-301.
20. Gonzalez-Islas C, Hablitz JJ. 2001. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. J Neurophysiol 86:2911-2918.
21. Gorelova N, Seamans JK, Yang CR. 2002. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 88:3150-3166.
22. Guidotti A, Auta J, Davis JM, Gerevini VD, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study [In Process Citation]. Arch Gen Psychiatry 57:1061-1069.
23. Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, Arnold SE, Bilker WB, Gur RC. 2000. Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry 57:769-775.
24. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. 2002. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59:521-529.
25. Joyce JN, Lexow N, Bird E, Winokur A. 1988. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2:546-557.
26. Kornhuber J, Riederer P, Reynolds GP, Beckmann H, Jellinger K, Gabriel E. 1989. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm 75:1-10.
27. Laprade N, Soghomonian JJ. 1995. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Brain Res Mol Brain Res 34:65-74.
28. Laprade N, Soghomonian JJ. 1997. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons. Brain Res Mol Brain Res 48:333-345.
29. Lavin A, Grace AA. 2001. Stimulation of D1-type dopamine receptors enhances excitability in prefrontal cortical pyramidal neurons in a state-dependent manner. Neuroscience 104:335-346.
30. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH. 1987. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 7:279-290.
31. Lidow MS, Elsworth JD, Goldman-Rakic PS. 1997. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J Pharmacol Exp Ther 281:597-603.
32. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME. 1999. MRI anatomy of schizophrenia. Biol Psychiatry 45:1099-1119.
33. Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ. 1997. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry 54:1089-1095.
34. Muly EC, 3rd, Szigeti K, Goldman-Rakic PS. 1998. D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J Neurosci 18:10553-10565.
35. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. 1998. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433-440.
36. O'Donnell P, Tseng KY. 2004. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24:5131-5139.
37. Pralong E, Jones RSG. 1993. Interactions of dopamine with glutamate-mediated and GABA-mediated synaptic transmission in the rat entorhinal cortex in vitro. Eur J Neurosci 5:760-767.
38. Retaux S, Besson MJ, Penit-Soria J. 1991. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices. Neuroscience 42:61-71.
39. Sakai K, Gao XM, Hashimoto T, Tamminga CA. 2001. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse 39:152-160.
40. Scheel-Kruger J. 1986. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol Scand 73(Suppl 107):7-49.
41. Seamans JK, Gorelova N, Durstewitz D, Yang CR. 2001a. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21:3628-3638.
42. Seamans JK, Durstewitz D, Christie BR, Stevens CF, Sejnowski TJ. 2001b. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA 98:301-306.
43. Smiley JF, Goldman-Rakic PS. 1993. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb Cortex 3:223-238.
44. Tamminga CA. 1998. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12:21-36.
45. Urban NN, Gonzalez-Burgos G, Henze DA, Lewis DA, Barrionuevo G. 2001. Selective reduction by dopamine of excitatory synaptic inputs to pyramidal neurons in primate prefrontal cortex. J Physiol 539.3:707-712.
46. Toru M, Nishikawa T, Malaga N, Takashima M. 1982. Dopamine metabolism increases in post-mortem schizophrenic basal ganglia. J Neural Transm 54:181-191.
47. Vincent SL, Khan Y, Benes FM. 1993. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J Neurosci 13:2551-2564.
48. Vincent SL, Khan Y, Benes FM. 1995. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 19:112-120.
49. Waddington JL, Cross AJ, Gamble SJ, Bourne RC. 1983. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments. Adv Biochem Psychopharmacol 37:299-308.
50. Zhang ZJ, Reynolds GP. 2002. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 55:1-10.